Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Controlled gene delivery system based on thermosensitive biodegradable hydrogel.

Zhenhua Li1, Wen Ning, Jumei Wang

  • 1Center for Pharmacogenetics, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA.

Pharmaceutical Research
|June 24, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter: Testosterone Does Not Drive Prostate Cancer: Presenting the New Framework of Androgen Adequacy vs Inadequacy.

The Journal of urology·2026
Same author

Why bladder emptying reduces the false-positive results of dynamic renal scintigraphy?

International urology and nephrology·2026
Same author

Re: Dao et al., <i>In situ</i> observation of urothelial responses to NaCl-induced osmotic stress using optical coherence tomography.

Journal of biomedical optics·2026
Same author

Targeted deletion of macrophage ferritin heavy chain protects from macrophage ferroptosis in acute respiratory distress syndrome.

Research square·2026
Same author

Endogenous vasopressin and vasopressin receptor 2 in bladder as anti-diuretic / anti-spasmodic targets for the treatment of multifactorial nocturia.

Continence (Amsterdam, Netherlands)·2026
Same author

Are There Potential New Therapeutic Avenues for Treating Idiopathic Nocturia? ICI-RS 2025.

Neurourology and urodynamics·2025

A novel biodegradable triblock copolymer forms a hydrogel at body temperature, enabling controlled plasmid DNA (pDNA) delivery for gene therapy. This system shows low cytotoxicity and effective gene expression in wound healing models.

Area of Science:

  • Biomaterials Science
  • Gene Therapy
  • Polymer Chemistry

Background:

  • Current synthetic polymer pDNA delivery systems often lack biodegradability or environmental responsiveness.
  • Developing advanced delivery vectors is crucial for effective gene therapy applications.

Purpose of the Study:

  • To create and assess a thermosensitive, biodegradable, and biocompatible triblock copolymer for controlled pDNA delivery.
  • To evaluate the copolymer's performance in vitro and in vivo for gene therapy applications.

Main Methods:

  • Synthesis of poly[ethylene glycol-b-(D, L-lactic acid-co-glycol acid)-b-ethylene glycol] (PEG-PLGA-PEG) triblock copolymers.
  • Characterization of molecular weight, polydispersity, and cytotoxicity (MTT assay).
  • In vitro pDNA release studies at 37°C and gene transfection efficiency assessment in a mouse skin wound model.

Related Experiment Videos

Main Results:

  • PEG-PLGA-PEG dispersions exhibited a phase transition from liquid at room temperature to hydrogel at 37°C.
  • The copolymer demonstrated in vitro degradation over 30 days and significantly lower cytotoxicity compared to poly-L-lysine hydrochloride.
  • Controlled pDNA release followed zero-order kinetics for 12 days, with maximal luciferase gene expression observed at 24 hours post-delivery in mice.

Conclusions:

  • The PEG-PLGA-PEG hydrogel is a promising platform for pDNA delivery.
  • This represents a novel, non-viral vector strategy for gene therapy, particularly in wound healing applications.